Advertisement

Late relapse of anti-N-methyl-d-aspartate receptor encephalitis with amusia and transiently reduced uptake in 123I-iomazenil single-photon emission computed tomography

      Abstract

      Introduction

      Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis has a high relapse rate at approximately 10–20%. Most relapses occur within 2 years from onset, and 5 years after onset is rare. We report a case of anti-NMDAR encephalitis relapse with amusia 10 years after the initial encephalitis and discuss the usefulness of 123I-iomazenil single-photon emission computerized tomography (IMZ-SPECT) for its diagnosis.

      Case

      A 13-year-old left-handed girl presented with a depressed level of consciousness and focal to bilateral tonic-clonic seizures. Cerebrospinal fluid (CSF) analysis showed a mildly increased white blood cell count, elevated neopterin levels, and positive oligoclonal bands. Brain MRI was normal. IMZ-SPECT revealed reduced uptake in the right frontoparietal region. She received intravenous pulse methylprednisolone (IVMP) and high-dose intravenous immunoglobulin for autoimmune encephalitis; her symptoms resolved without neurological deficits. At 23 years old, she had mild right-sided numbness, dysarthria, amusia, and tonic-clonic seizures. Although the CSF analysis and brain MRI were normal, IMZ-SPECT revealed reduced uptake, indicating a relapse of encephalitis. IVMP administration resolved the symptoms. After discharge, the initial and relapse CSF analysis revealed anti-NMDAR antibodies.

      Conclusion

      An anti-NMDAR encephalitis relapse 10 years after onset has never been reported. IMZ-SPECT may help in the diagnosis of anti-NMDAR encephalitis.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Brain and Development
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Dalmau J.
        • Gleichman A.J.
        • Hughes E.G.
        • Rossi J.E.
        • Peng X.
        • Lai M.
        • et al.
        Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.
        Lancet Neurol. 2008; 7: 1091-1098
        • Nosadini M.
        • Granata T.
        • Matricardi S.
        • Freri E.
        • Ragona F.
        • Papetti L.
        • et al.
        Relapse risk factors in anti-N-methyl-D-aspartate receptor encephalitis.
        Dev Med Child Neurol. 2019; 61: 1101-1107
        • Titulaer M.J.
        • McCracken L.
        • Gabilondo I.
        • Armangué T.
        • Glaser C.
        • Iizuka T.
        • et al.
        Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.
        Lancet Neurol. 2013; 12: 157-165
        • Chiang S.
        • Garg T.
        • Hu A.
        • Amin H.
        • Davalos-Balderas A.
        • Alfradique-Dunham I.
        • et al.
        Pearls & oy-sters: relapse of anti-NMDA receptor encephalitis after prior first- and second-line immunotherapy.
        Neurology. 2018; 90: 936-939
        • Dalmau J.
        • Bataller L.
        Limbic encephalitis: the new cell membrane antigens and a proposal of clinical-immunological classification with therapeutic implications.
        Neurologia. 2007; 22: 526-537
        • Gabilondo I.
        • Saiz A.
        • Galan L.
        • Gonzalez V.
        • Jadraque R.
        • Sabater L.
        • et al.
        Analysis of relapses in anti-NMDAR encephalitis.
        Neurology. 2011; 77: 996-999
        • Gresa-Arribas N.
        • Titulaer M.J.
        • Torrents A.
        • Aguilar E.
        • McCracken L.
        • Leypoldt F.
        • et al.
        Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study.
        Lancet Neurol. 2014; 13: 167-177
        • Benarroch E.E.
        Insular cortex: functional complexity and clinical correlations.
        Neurology. 2019; 93: 932-938
        • Sihvonen A.J.
        • Sarkamo T.
        • Rodriguez-Fornells A.
        • Ripolles P.
        • Munte T.F.
        • Soinila S.
        Neural architectures of music – Insights from acquired amusia.
        Neurosci Biobehav Rev. 2019; 107: 104-114
        • Moreno-Ajona D.
        • Prieto E.
        • Grisanti F.
        • Esparragosa I.
        • Sánchez Orduz L.
        • Gállego Pérez-Larraya J.
        • et al.
        18F-FDG-PET imaging patterns in autoimmune encephalitis: impact of image analysis on the results.
        Diagnostics (Basel). 2020; 10: 356
        • Llorens V.
        • Gabilondo I.
        • Gómez-Esteban J.C.
        • Agundez M.
        • Mendibe M.
        • Bergara J.C.
        • et al.
        Abnormal multifocal cerebral blood flow on Tc-99m HMPAO SPECT in a patient with anti-NMDA-receptor encephalitis.
        J Neurol. 2010; 257: 1568-1569
        • Kasahara H.
        • Sato M.
        • Nagamine S.
        • Makioka K.
        • Tanaka K.
        • Ikeda Y.
        Temporal changes on 123I-Iomazenil and cerebral blood flow single-photon emission computed tomography in a patient with anti-N methyl-D-aspartate receptor encephalitis.
        Intern Med. 2019; 58: 1501-1505
        • Dalmau J.
        • Armangué T.
        • Planagumà J.
        • Radosevic M.
        • Mannara F.
        • Leypoldt F.
        • et al.
        An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models.
        Lancet Neurol. 2019; 18: 1045-1057